Skip to main content
SpringerLink
Log in

Pulmonary Complications of Liver Disease

  • Chapter
  • First Online:
Liver Anesthesiology and Critical Care Medicine

  • 1280 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Przybyłowski T, Krenke R, Fangrat A, et al. Gas exchange abnormalities in patients listed for liver transplantation. J Physiol Pharmacol. 2006;57(Suppl 4):313–23.

    PubMed  Google Scholar 

  2. Agustí AG, Roca J, Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis. J Hepatol. 1990;10:251–7.

    Article  PubMed  Google Scholar 

  3. Mohamed R, Freeman JW, Guest PJ, et al. Pulmonary gas exchange abnormalities in liver transplant candidates. Liver Transpl. 2002;8:802–8.

    Article  PubMed  Google Scholar 

  4. Yao EH, Kong BC, Hsue GL, et al. Pulmonary function changes in cirrhosis of the liver. Am J Gastroenterol. 1987;82:352–4.

    CAS  PubMed  Google Scholar 

  5. Yigit IP, Hacievliyagil SS, Seckin Y, et al. The relationship between severity of liver cirrhosis and pulmonary function tests. Dig Dis Sci. 2008;53:1951–6.

    Article  PubMed  Google Scholar 

  6. Martínez GP, Barberà JA, Visa J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol. 2001;34:651–7.

    Article  PubMed  Google Scholar 

  7. Martínez-Palli G, Gómez FP, Barberà JA, et al. Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation. World J Gastroenterol. 2006;12:5878–83.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Castaing Y, Manier G. Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients. Chest. 1989;96:1064–9.

    Article  CAS  PubMed  Google Scholar 

  9. Naeije R, Halleman R, Mols P, Melot C. Hypoxic pulmonary vasoconstriction in liver cirrhosis. Chest. 1981;80:570–4.

    Article  CAS  PubMed  Google Scholar 

  10. Degano B, Mittaine M, Guénard H, et al. Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J Appl Physiol. 2009;107:139–43.

    Article  CAS  PubMed  Google Scholar 

  11. Andrivet P, Cadranel J, Housset B, et al. Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin. Chest. 1993;103:500–7.

    Article  CAS  PubMed  Google Scholar 

  12. Kim BJ, Lee SC, Park SW, et al. Characteristics and prevalence of intrapulmonary shunt detected by contrast echocardiography with harmonic imaging in liver transplant candidates. Am J Cardiol. 2004;94:525–8.

    Article  PubMed  Google Scholar 

  13. Rodríguez-Roisin R, Krowka MJ, Hervé P, et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24:861–80.

    Article  PubMed  Google Scholar 

  14. Hourani JM, Bellamy PE, Tashkin DP, et al. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med. 1991;90:693–700.

    Article  CAS  PubMed  Google Scholar 

  15. Wagner PD, Rodriguez-Roisin R. Clinical advances in pulmonary gas exchange. Am Rev Respir Dis. 1991;143:883–8.

    Article  CAS  PubMed  Google Scholar 

  16. Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver-induced lung vascular disorder. N Engl J Med. 2008;358:2378–87.

    Article  PubMed  Google Scholar 

  17. Matsubara O, Nakamura T, Uehara T, Kasuga T. Histometrical investigation of the pulmonary artery in severe hepatic disease. J Pathol. 1984;143:31–7.

    Article  CAS  PubMed  Google Scholar 

  18. Moyer K, Balistreri W. Hepatobiliary disease in patients with cystic fibrosis. Curr Opin Gastroenterol. 2009;25:272–8.

    Article  PubMed  Google Scholar 

  19. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352:1992–2001.

    Article  CAS  PubMed  Google Scholar 

  20. Fairbanks KD, Tavill AS. Liver disease in alpha 1-antitrypsin deficiency: a review. Am J Gastroenterol. 2008;103:2136–41.

    Article  CAS  PubMed  Google Scholar 

  21. Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519–31. https://doi.org/10.1016/S0140-6736(16)00576-6. [Epub ahead of print].

    Article  CAS  PubMed  Google Scholar 

  22. Nick JA, Chacon CS, Brayshaw SJ, et al. Effects of gender and age of diagnosis on disease progression in long-term cystic fibrosis survivors. Am J Respir Crit Care Med. 2010;182(5):614–26.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Farrell PM, Rosensteinn BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4–14.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rodman DM, Polis JM, Heltshe SL, et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med. 2005;171(6):621.

    Article  PubMed  Google Scholar 

  25. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2006;173:475–82.

    Article  PubMed  Google Scholar 

  26. Wilschanski M. Patterns of gastrointestinal disease associated with mutations of CFTR. Curr Gastroenterol Rep. 2008;10:316–23.

    Article  PubMed  Google Scholar 

  27. Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis. 2001;21:471–88.

    Article  CAS  PubMed  Google Scholar 

  28. Lindblad A, Glaumann H, Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology. 1998;27:166–74.

    Article  CAS  PubMed  Google Scholar 

  29. Desmond CP, Wilson J, Bailey M, et al. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. Liver Int. 2007;27:1402–8.

    CAS  PubMed  Google Scholar 

  30. Gooding I, Dondos V, Gyi KM, et al. Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation. Liver Transpl. 2005;11:1522–6.

    Article  PubMed  Google Scholar 

  31. Siano M, De Gregorio F, Boggia B, et al. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. Dig Liver Dis. 2010;42:428–31.

    Article  CAS  PubMed  Google Scholar 

  32. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23:299–323.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Black SM, Woodley FW, Tumin D, et al. Cystic fibrosis associated with worse survival after liver transplantation. Dig Dis Sci. 2016;61:1178–85.

    Article  CAS  PubMed  Google Scholar 

  34. Fridell JA, Bond GJ, Mazariegos GV, et al. Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center’s experience. J Pediatr Surg. 2003;38:1152–6.

    Article  PubMed  Google Scholar 

  35. Molmenti EP, Squires RH, Nagata D, et al. Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr Transplant. 2003;7:93–7.

    Article  PubMed  Google Scholar 

  36. Ikegami T, Sanchez EQ, Uemura T, et al. Liver transplantation for cystic fibrosis in adults. Surg Today. 2008;38:26–9.

    Article  PubMed  Google Scholar 

  37. Kelly E, Greene CM, Carroll TP, et al. Alpha-1 antitrypsin deficiency. Respir Med. 2010;104:763–72.

    Article  PubMed  Google Scholar 

  38. Topic A, Alempijevic T, Milutinovic AS, Kovacevic N. Alpha-1-antitrypsin phenotypes in adult liver disease patients. Ups J Med Sci. 2009;114:228–34.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Chappell S, Hadzic N, Stockley R, et al. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease. Hepatology. 2008;47:127–32.

    Article  CAS  PubMed  Google Scholar 

  40. Stoller JA, Aboussouan A. A review of α1 antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246–59.

    Article  CAS  PubMed  Google Scholar 

  41. Lindblad D, Blomenkamp K, Teckman J. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model. Hepatology. 2007;46:1228–35.

    Article  CAS  PubMed  Google Scholar 

  42. Mahadeva R, Chang WS, Dafforn TR, et al. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest. 1999;103:999–1006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Hinds R, Hadchouel A, Shanmugham NP, Al-Hussaini A, et al. Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease. J Pediatr Gastroenterol Nutr. 2006;43:136–8.

    Article  CAS  PubMed  Google Scholar 

  44. Bowlus CL, Willner I, Zern MA, et al. Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol. 2005;3:390–6.

    Article  CAS  PubMed  Google Scholar 

  45. Tonelli AR, Rouhani F, Li N, et al. Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank. Int J Chron Obstruct Pulmon Dis. 2009;4:443–52.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Meyer CA, White CS, Sherman KE. Diseases of the hepatopulmonary axis. Radiographics. 2000;20:687–98.

    Article  CAS  PubMed  Google Scholar 

  47. Curtis JR, Beukelman T, Onofrei A, et al. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Ann Rheum Dis. 2010;69:43–7.

    Article  CAS  PubMed  Google Scholar 

  48. Sokolove J, Strand V, Greenberg JD, et al. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(9):1612–7.

    Article  CAS  PubMed  Google Scholar 

  49. Jones DE. Pathogenesis of primary biliary cirrhosis. J Hepatol. 2003;39:639–48.

    Article  CAS  PubMed  Google Scholar 

  50. Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570–80.

    Article  CAS  PubMed  Google Scholar 

  51. Liu B, Zhang FC, Zhang ZL, et al. Interstitial lung disease and Sjögren’s syndrome in primary biliary cirrhosis: a causal or casual association? Clin Rheumatol. 2008;27:1299–306.

    Article  PubMed  Google Scholar 

  52. Neuhauser M, Bjornsson E, Treeprasertsuk S, et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol. 2010;105:345–53.

    Article  CAS  PubMed  Google Scholar 

  53. Shen M, Zhang F, Zhang X. Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients. J Clin Gastroenterol. 2009;43:676–9.

    Article  PubMed  Google Scholar 

  54. Kerkar N, Yanni G. “De Novo” and “recurrent” autoimmune hepatitis after liver transplantation: a comprehensive review. J Autoimmun. 2016;16:17–24. https://doi.org/10.1016/j.jaut.2015.08.017.

    Article  Google Scholar 

  55. Schramm C, Bubenheim M, Adam R, et al. European liver intestine transplant association. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl. 2010;16:461–9.

    PubMed  Google Scholar 

  56. Silveira MG, Talwalkar JA, Lindor KD, Wiesner RH. Recurrent primary biliary cirrhosis after liver transplantation. Am J Transplant. 2010;10:720–6.

    Article  CAS  PubMed  Google Scholar 

  57. Torring PM, Larsen MJ, Kiedsen AD, et al. Global gene expression of telangectisial tissue from patients with hereditary telangiectasia. Microvasc Res. 2015;99:118–26.

    Article  PubMed  CAS  Google Scholar 

  58. Buonamico P, Suppressa P, Lenato GM, et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color-Doppler vs multislice computed tomography study. J Hepatol. 2008;48:811–20.

    Article  PubMed  Google Scholar 

  59. Memeo M, Stabile Ianora AA, et al. Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs. Radiol Med. 2005;109:125–38.

    CAS  PubMed  Google Scholar 

  60. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol. 2007;46:499–507.

    Article  CAS  PubMed  Google Scholar 

  61. Rozenberg D, Leek E, Faughnan ME. Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia [HHT]. Respir Med. 2015;109:768–77.

    Article  PubMed  Google Scholar 

  62. Cottin V, Plauchu H, Bayle JY, et al. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med. 2004;169:994–1000.

    Article  PubMed  Google Scholar 

  63. Faughnan ME, Granton JT, Young LH. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J. 2009;33:1186–94.

    Article  CAS  PubMed  Google Scholar 

  64. Epperla N, Hocking W. Blessing for the bleeder bevacizumab in hereditary hemorrhagic telangiectasia. Clin Med Res. 2015;13:32–5.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Lerut J, Orlando G, Adams R, et al. Liver transplantation for hereditary hemorrhagic telangiectasia: reprot of the European liver transplant registry. Ann Surg. 2006;244:854–62.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax–pathophysiology, diagnosis and treatment—review of the literature. Liver Int. 2004;24(4):281.

    Article  PubMed  Google Scholar 

  67. Sese E, Xiol X, Castellote J, et al. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol. 2003;36:75–7.

    Article  CAS  PubMed  Google Scholar 

  68. Ferrante D, Arguedas MR, Cerfolio RJ, et al. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97:3172–5.

    Article  PubMed  Google Scholar 

  69. Ditah IC, Bawardy BF, Saberi B, et al. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatohydrothorax: a systematic review and cumulative meta-analysis. Wrold J Hepatol. 2015;13:1797–806.

    Article  Google Scholar 

  70. Almaslmani M, Derbala MF, Albozom I, et al. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis jiroveci infection in orthotopic liver transplantation. Transpl Infect Dis. 2008;10:339–42.

    Article  CAS  PubMed  Google Scholar 

  71. Witte L, Rupp J, Heyer P, et al. Fibrosing alveolitis with hepatitis C-related cryoglobulinemia. Dtsch Med Wochenschr. 2008;133:709–12.

    Article  CAS  PubMed  Google Scholar 

  72. Howard L, Gopalan D, Griffiths M, Mahadeva R. Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate. Chest. 2006;129:1718–21.

    Article  PubMed  Google Scholar 

  73. Carrillo-Esper R, González-Avila D, Uribe-Ríos M, Méndez-Sánchez N. Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C: case report. Ann Hepatol. 2008;7:87–90.

    PubMed  Google Scholar 

  74. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med. 2005;26:587–97.

    Article  PubMed  Google Scholar 

  75. Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401–9.

    Article  PubMed  Google Scholar 

  76. Thenappan T, Ryan JJ, Archer SL. Evolving epidemiology of pulmonary arterial hypertension. Am J Crit Care Med. 2012;186:707–9.

    Article  Google Scholar 

  77. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;34:2493–537.

    Google Scholar 

  78. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000;6:453–8.

    Article  PubMed  Google Scholar 

  79. D’Alto M, Romeo E, Argiento P, et al. Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. Int J Cardiol. 2013;168:4058–62.

    Article  PubMed  Google Scholar 

  80. Roberts KE, Fallon MB, Krowka MJ, et al. Pulmonary Vascular Complications of Liver Disease Study Group. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med. 2009;179:835–42.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol. 2010;23:145–50.

    Article  PubMed  Google Scholar 

  82. Porres-Aguilar M, Zuckerman MJ, Figueroa-Casas JB, Krowka MJ. Portopulmonary hypertension: state of the art. Ann Hepatol. 2008;7:321–30.

    PubMed  Google Scholar 

  83. Ghofrani HA, Humbert M. The role of combination in managing pulmonary arterial hypertension. Eur Respir Rev. 2014;134:469–75.

    Article  Google Scholar 

  84. Swanson KL, Wiesner RH, Nyberg SL, et al. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008;8:2445–53.

    Article  CAS  PubMed  Google Scholar 

  85. Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol. 1991;17:492–8.

    Article  CAS  PubMed  Google Scholar 

  86. Le Pavec J, Souza R, Herve P, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med. 2008;178:637–43.

    Article  PubMed  Google Scholar 

  87. Goldberg DS, Batra S, Sahay S, et al. MELD exceptions for portopulmonary hypertension. Current policy and future implications. Am J Transplant. 2014;9:2081–7.

    Article  Google Scholar 

  88. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl. 2006;12(12 Suppl 3):S105–7.

    Article  PubMed  Google Scholar 

  89. Rafanan AL, Maurer J, Mehta AC, Schilz R. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol. Chest. 2000;118:1497–500.

    Article  CAS  PubMed  Google Scholar 

  90. Koneru B, Ahmed S, Weisse AB, et al. Resolution of pulmonary hypertension of cirrhosis after liver transplantation. Transplantation. 1994;58:1133–5.

    Article  CAS  PubMed  Google Scholar 

  91. Pascasio JM, Grilo I, Lopez-Pardo FJ, et al. Prevalence and severity of Hepatopulmonary syndrome and its influence on survival on cirrhotic patients evaluated for transplantation. Am J Transplant. 2014;14:1391–9.

    Article  CAS  PubMed  Google Scholar 

  92. Fierro Alanis MP, Bastón Rey I, Nieves-Maldonado S. Platypnea-orthodeoxia syndrome: Importance of patient position for correct diagnosis at the time of (99m)Tc-MAA injection. Rev Esp Med Nucl Imagen Mol. 2015;34:261–3.

    CAS  PubMed  Google Scholar 

  93. El-Shabrawi MH, Omran S, Wageeh S, et al. 99mTechnetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease. Eur J Gastroenterol Hepatol. 2010;22(8):1006–12.

    Article  CAS  PubMed  Google Scholar 

  94. Rodriguez-Roisin R, Roca J, Agusti AG, et al. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis. 1987;135:1085–92.

    CAS  PubMed  Google Scholar 

  95. Gómez FP, Martínez-Pallí G, Barberà JA, et al. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology. 2004;40:660–6.

    Article  PubMed  Google Scholar 

  96. Degano B, Mittaine M, Hervé P, et al. Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. Eur Respir J. 2009;34:138–44.

    Article  CAS  PubMed  Google Scholar 

  97. Gómez FP, Barberà JA, Roca J, et al. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006;43:1084–91.

    Article  PubMed  CAS  Google Scholar 

  98. Tang L, Luo B, Patel RP, et al. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1467–72.

    Article  CAS  PubMed  Google Scholar 

  99. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004;10:174–82.

    Article  PubMed  Google Scholar 

  100. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology. 2005;41:1122–9.

    Article  PubMed  Google Scholar 

  101. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology. 2003;37:192–7.

    Article  PubMed  Google Scholar 

  102. Benítez C, Arrese M, Jorquera J, et al. Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation. Ann Hepatol. 2009;8:71–4.

    PubMed  Google Scholar 

  103. De BK, Sen S, Biswas PK, et al. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology. 2002;122:897–903.

    Article  PubMed  Google Scholar 

  104. Nayyar D, Man HS, Granton J, et al. Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome. Am J Transplant. 2015;15:903–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Schiffer E, Majno P, Mentha G, et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant. 2006;6:1430–7.

    Article  CAS  PubMed  Google Scholar 

  106. Taille C, Cadranel J, Bellocq A, et al. Liver transplantation for hepatopulmonary syndrome: a ten year experience in Paris, France. Transplantation. 2003;75:1482–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University of Colorado, Aurora, CO, USA

    Mercedes Susan Mandell MD, PhD

  2. Department of Surgery, Hokkaido University, Sappora, Japan

    Masahiko Taniguchi MD, FACS

Authors
  1. Mercedes Susan Mandell MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahiko Taniguchi MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mercedes Susan Mandell MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Columbia University Medical Center, New York, New York, USA

    Gebhard Wagener

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mandell, M.S., Taniguchi, M. (2018). Pulmonary Complications of Liver Disease. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-64298-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64298-7_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64297-0

  • Online ISBN: 978-3-319-64298-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation